GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Concord Medical Co Ltd (ROCO:6518) » Definitions » Debt-to-Equity

Concord Medical Co (ROCO:6518) Debt-to-Equity : 0.33 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Concord Medical Co Debt-to-Equity?

Concord Medical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$34.6 Mil. Concord Medical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$189.1 Mil. Concord Medical Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$671.5 Mil. Concord Medical Co's debt to equity for the quarter that ended in Jun. 2024 was 0.33.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Concord Medical Co's Debt-to-Equity or its related term are showing as below:

ROCO:6518' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.3   Med: 0.69   Max: 0.87
Current: 0.33

During the past 12 years, the highest Debt-to-Equity Ratio of Concord Medical Co was 0.87. The lowest was 0.30. And the median was 0.69.

ROCO:6518's Debt-to-Equity is ranked worse than
58.89% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs ROCO:6518: 0.33

Concord Medical Co Debt-to-Equity Historical Data

The historical data trend for Concord Medical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Co Debt-to-Equity Chart

Concord Medical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.67 0.34 0.30 0.32

Concord Medical Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.30 0.30 0.32 0.33

Competitive Comparison of Concord Medical Co's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Concord Medical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Concord Medical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Concord Medical Co's Debt-to-Equity falls into.



Concord Medical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Concord Medical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Concord Medical Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Co  (ROCO:6518) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Concord Medical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Concord Medical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Number 266, Wenhua Road, 12F, Sec.1, 12th Floor, Banqiao District, New Taipei City, Taipei, TWN, 22041
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.

Concord Medical Co Headlines

No Headlines